L. Ziemba

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, rando

J. Stringer, P. Sax, S. Lockman, 2021, The Lancet.

Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092

P. Musoke, F. Aweeka, J. Moye, 2021, The Pediatric infectious disease journal.

Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe

L. Aurpibul, J. Currier, M. Fowler, 2019, AIDS and Behavior.

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial.

P. Sax, S. Lockman, J. Currier, 2023, The lancet. HIV.

Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial.

S. Lockman, S. Brummel, S. Moyo, 2024, Journal of acquired immune deficiency syndromes.